TITLE

2008 - Review: Perioperative beta-blockers provide no clear benefit in patients having noncardiac surgery

AUTHOR(S)
McColl, Ryan J.; Dixon, Elijah
PUB. DATE
March 2009
SOURCE
ACP Journal Club;3/17/2009, Vol. 150 Issue 3, p2
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article deliberates on whether perioperative use of beta-blockers prevent short-term cardiovascular (CV) events in patients who underwent non-cardiac surgery. Research conducted reveal that beta-blocker therapy reduced risk for non-fatal myocardial infarction (MI) and myocardial ischemia and increased risk for stroke. It was concluded that in patients having non-cardiac surgery, perioperative use of beta-blockers provides no clear benefit in preventing short-term cardiovascular events.
ACCESSION #
38421568

 

Related Articles

  • Beta-blockers: recognising the assets in relation to coronary artery disease. Kendall, M. J. // Basic Research in Cardiology;Nov2000 Supplement 1, Vol. 95, pI31 

    Beta-blockers have been shown to reduce the risk of coronary events and reduce the mortality of patients with hypertension and in those who have had a myocardial infarction. Furthermore, the evidence for long-term benefits in these two patient groups are much more convincing for beta-blockers...

  • Beta Blockers Not Associated with Lower Morbidity/Mortality in Adults with CAD or CAD Risk Factors. SLAWSON, DAVID // American Family Physician;3/1/2013, Vol. 87 Issue 5, p373 

    The article presents an overview of a study which examined the use of beta blockers in adult patients with a history of myocardial infarction (MI), known coronary artery disease (CAD) or risk factors for CAD. It references the study "REACH Registry Investigators. Î’-Blocker Use and Clinical...

  • Sudden death: ACE inhibitors and beta-blockers. Landray, M. J. // Basic Research in Cardiology;Nov2000 Supplement 1, Vol. 95, pI37 

    Sudden death is extremely common in patients suffering from cardiovascular diseases. At least one third of those with hypertension and probably about half of those who survive a myocardial infarction or suffer from cardiac failure who die in a clinical trial, die suddenly. Beta-blockers reduce...

  • β-Blockers in coronary artery disease management. Boudonas, G. E. // Hippokratia;Oct-Dec2010, Vol. 14 Issue 4, p231 

    Beta-blockers are a multiform group of drugs with multiple applications in the treatment of patients with cardiovascular disease. Their adverse actions are multiple and relate mainly to the β-adrenergic receptor blockade. They are used to treat all forms of coronary disease, but especially in...

  • Underutilization of beta blockers after infarction in the elderly. Huffman, Grace Brooke // American Family Physician;5/15/1998, Vol. 57 Issue 10, p2530 

    Presents information from the article `Underutilization of Beta-blockers in Older Patients With Prior Myocardial Infarction or Coronary Artery Disease in an Academic, Hospital-based Geriatrics Practice.' by G. Mendelson and W.S. Aronow, which was published in the `Journal of American Geriatrics...

  • Beta-Blocker Use in Situations Other than Just Post-MI.  // Internal Medicine Alert;11/15/2012, Vol. 34 Issue 21, p167 

    The article presents information regarding the usage of Beta-Blocker drugs in indications like coronary artery disease (CAD) other than post-myocardial infarction (MI).

  • Beta-Blocker Use in Situations Other than Just Post-MI. Kuritzky, Louis // Neurology Alert;Dec2012 Clinical Briefs In Primary Care, p23 

    The article briefly discusses a study which shows that the long-term use of beta-blockers in the standard-of-care management of post-myocardial infarction (MI) patients with known coronary artery disease (CAD) did not improve outcomes except for the few short years immediately after an MI.

  • ß-Blockers for secondary prevention in stable coronary artery disease: can observational studies provide valid answers? Floyd, James S. // Heart;Nov2014, Vol. 100 Issue 22, p1741 

    The author reflects on the use of beta-blockers (BBs) for secondary prevention in stable coronary artery disease (CAD) and states that beta-blockers is an important secondary prevention therapy for patients with acute myocardial infarction (AMI). The author further expands on two studies...

  • Cardiovascular highlights from non-cardiology journals. O'Flaherty, Martin; Huffman, Mark D.; Capewell, Simon // Heart;Sep2015, Vol. 101 Issue 17, p1433 

    The article focuses on a study on decreasing mortality rates of acute myocardial infarction (AMI) and coronary heart disease (CHD). Topics discussed include a decrease in mortality rates shown by multinational monitoring of trends and determinants in cardiovascular disease (MONICA) project...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics